Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias

Abstract

The invention relates to vaccines for treating prostate inflammation and benign prostate hyperplasias (stages I and II) comprising Lactobacillus strains in an inactivated form and carriers and/or excipients commonly used in vaccine preparations.

1 . A process for treating a patient suffering from prostate inflammation, benign prostate hyperplasia stage I, or benign prostate hyperplasia stage II, said process comprising vaccinating the patient with a vaccine, said vaccine containing an effective amount of a mixture of  Lactobacillus plantarum, Lactobacillus paracasei  and  Lactobacillus fermentum  in its inactivated form. 
     
     
         2 . A method of treating a patient suffering from prostate inflammation, benign prostate hyperplasia stage I, or benign prostate hyperplasia stage II, said method comprising vaccinating said patient intramuscularly with an effective dose of a suspension of a mixture of  Lactobacillus plantarum, Lactobacillus paracasei  and  Lactobacillus fermentum  in its inactivated form. 
     
     
         3 . The method of  claim 2 , wherein the patient is suffering from a benign hyperplasia stage I or II. 
     
     
         4 . The method of  claim 2 , wherein said  Lactobacillus  strains previously have been cultivated from women suffering from gynecologic inflammations of bacterial origin.